>AT3G45140.1 |  LOX2 (LIPOXYGENASE 2) lipoxygenase 
MYCRESLSSLQTLNVAKSLSSLFPKQSALINPISAGRRNNLPRPNLRRRCKVTASRANIE 
QEGNTVKEPIQNIKVKGYITAQEEFLEGITWSRGLDDIADIRGRSLLVELISAKTDQRIT 
VEDYAQRVWAEAPDEKYECEFEMPEDFGPVGAIKIQNQYHRQLFLKGVELKLPGGSITFT 
CESWVAPKSVDPTKRIFFSDKSYLPSQTPEPLKKYRKEELETLQGKNREEVGEFTKFERI 
YDYDVYNDVGDPDNDPELARPVIGGLTHPYPRRCKTGRKPCETDPSSEQRYGGEFYVPRD 
EEFSTAKGTSFTGKAVLAALPSIFPQIESVLLSPQEPFPHFKAIQNLFEEGIQLPKDAGL 
LPLLPRIIKALGEAQDDILQFDAPVLINRDRFSWLRDDEFARQTLAGLNPYSIQLVEEWP 
LISKLDPAVYGDPTSLITWEIVEREVKGNMTVDEALKNKRLFVLDYHDLLLPYVNKVREL 
NNTTLYASRTLFFLSDDSTLRPVAIELTCPPNINKPQWKQVFTPGYDATSCWLWNLAKTH 
AISHDAGYHQLISHWLRTHACTEPYIIAANRQLSAMHPIYRLLHPHFRYTMEINARARQS 
LVNGGGIIETCFWPGKYALELSSAVYGKLWRFDQEGLPADLIKRGLAEEDKTAEHGVRLT 
IPDYPFANDGLILWDAIKEWVTDYVKHYYPDEELITSDEELQGWWSEVRNIGHGDKKDEP 
WWPVLKTQDDLIGVVTTIAWVTSGHHAAVNFGQYGYGGYFPNRPTTTRIRMPTEDPTDEA 
LKEFYESPEKVLLKTYPSQKQATLVMVTLDLLSTHSPDEEYIGEQQEASWANEPVINAAF 
ERFKGKLQYLEGVIDERNVNITLKNRAGAGVVKYELLKPTSEHGVTGMGVPYSISI*
>AT5G35620.2 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.2 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.1 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT 
DKITFNNHDDSRRSRFTV*
>AT5G35620.1 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT 
DKITFNNHDDSRRSRFTV*
>AT4G18040.1 |  EIF4E (EUKARYOTIC TRANSLATION INITATION FACTOR 4E) RNA binding / RNA cap binding / protein binding / translation initiation factor 
MAVEDTPKSVVTEEAKPNSIENPIDRYHEEGDDAEEGEIAGGEGDGNVDESSKSGVPESH 
PLEHSWTFWFDNPAVKSKQTSWGSSLRPVFTFSTVEEFWSLYNNMKHPSKLAHGADFYCF 
KHIIEPKWEDPICANGGKWTMTFPKEKSDKSWLYTLLALIGEQFDHGDEICGAVVNIRGK 
QERISIWTKNASNEAAQVSIGKQWKEFLDYNNSIGFIIHEDAKKLDRNAKNAYTA*
>AT5G18110.1 |  NCBP (NOVEL CAP-BINDING PROTEIN) RNA binding / translation initiation factor 
MEVLDRRDDEIRDSGNMDSIKSHYVTDSVSEERRSRELKDGDHPLRYKFSIWYTRRTPGV 
RNQSYEDNIKKMVEFSTVEGFWACYCHLARSSLLPSPTDLHFFKDGIRPLWEDGANCNGG 
KWIIRFSKVVSARFWEDLLLALVGDQLDDADNICGAVLSVRFNEDIISVWNRNASDHQAV 
MGLRDSIKRHLKLPHAYVMEYKPHDASLRDNSSYRNTWLRG*